Elan is a neuroscience-focused biotechnology company headquartered in Dublin, Ireland. It was incorporated as a private limited company in December 1969 and became a public limited company in January 1984. Elan's work includes research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease and autoimmune diseases, including multiple sclerosis.
| Website | http://www.elan.com |
| Ticker | ELN |
| Revenue | $15.6 million |
| Employees | 788 (281 on RocketReach) |
| Founded | 1969 |
| Phone | +353 1 604 0031 |
| Technologies |
JavaScript
,
HTML
,
PHP
+137 more
(view full list)
|
| Industry | Biotechnology, Science and Engineering, Pharmaceuticals, Health Care, Pharmaceutical |
| Web Rank | 821317 |
| Web Visits | 53400 |
| Keywords | Biologics, Biotechnology, Innovation, Neuroscience, Drug Development, Pharmaceutical Research, Clinical Trials, Biopharma, Therapeutics, Neurological Disorders, Brain Health, Central Nervous System, Drug Discovery, Research And Development, Life Sciences, Healthcare, Neurology |
| Competitors | Roche, Pfizer, Amgen, Novartis, AbbVie, Johnson & Johnson, Genentech, Biogen, Merck AH, Lilly India +46 more (view full list) |
Looking for a particular Elan Pharmaceuticals employee's phone or email?
The Elan Pharmaceuticals annual revenue was $15.6 million in 2026.
Christopher Scott is the Managing Partner of Elan Pharmaceuticals.
281 people are employed at Elan Pharmaceuticals.